Swiss Life Sciences Stock News

Swiss Life Holding earnings beat puts recent share performance in focus Swiss Life Holding (SWX:SLHN) surprised the market on 21 May 2026 with earnings that exceeded expectations for both EPS and revenue, driven by contributions from its diversified operations and asset management business. The company reported CHF 11,711.0 in revenue and CHF 1,231.0 in net income. Investors are now weighing these figures against the share price, which closed at CHF 860.00 and is down over the past month and...

Swissquote Group Holding (SWX:SQN) is back in focus after reporting strong 2024 earnings, with higher net income and revenue supported by solid trading volumes and a growing digital banking platform. See our latest analysis for Swissquote Group Holding. After the results, the share price has inched higher, with a 1-day share price return of 1.90% and a 7-day share price return of 2.56%. Year to date, however, the share price is down 17.89%, while the 5-year total shareholder return of 202.90%...

ams-OSRAM (SWX:AMS) has moved its TMF8829 sensor into full production, highlighting a camera-free approach to low-cost computer vision that can classify objects in real time for appliances, medical tools, and privacy-focused settings. See our latest analysis for ams-OSRAM. The TMF8829 launch comes as momentum around the stock has picked up, with a 1 month share price return of 97.59% and a 1 year total shareholder return of 204.43%, even though the 5 year total shareholder return is down...

The European market has recently experienced a positive shift, with the pan-European STOXX Europe 600 Index climbing 3.00% amid hopes for de-escalation in the Middle East, while major indices in Germany, France, Italy, and the UK also saw gains. In this context of cautious optimism and economic adjustments due to geopolitical tensions and inflation concerns, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation capabilities and resilience amidst...

ABB (SWX:ABBN) has introduced the R9e frame to expand its low voltage AC drive lineup. The new frame targets higher power, space constrained refrigeration applications, with cabinet optimised design. The R9e drive is specified to deliver up to 355 kW in a compact form factor for commercial and industrial use. For you as an investor, this move aligns with ABB's focus on electrification and automation equipment for industrial customers. Refrigeration in food and beverage production and...

Why Ypsomed Holding’s latest earnings matter for shareholders Ypsomed Holding (SWX:YPSN) just released full year results to March 31, 2026, reporting net income of CHF 221.93 million and basic earnings per share of CHF 16.31 from continuing operations. These figures compare with net income of CHF 87.5 million and basic earnings per share of CHF 6.41 a year earlier, putting earnings firmly in focus for anyone tracking the stock’s recent move. See our latest analysis for Ypsomed Holding. The...

As European markets experience a positive shift, with the STOXX Europe 600 Index climbing by 3.00% on hopes of Middle East de-escalation, investors are keenly observing opportunities amidst revised economic forecasts and inflation concerns. In this environment, identifying stocks that are trading below their estimated fair value can present compelling investment opportunities, particularly when market conditions suggest potential for recovery or growth.

If you are wondering whether Alcon's current share price reflects its true worth, the stock's recent performance and fundamentals give you plenty to think about. Alcon last closed at $53.28, with the stock up 5.7% over the past week, but down 10.2% over the past month and down 16.1% year to date. This adds context to a 24.5% decline over the last year and a 24.8% decline over three years. These moves sit against a longer backdrop where the stock is down 13.7% over five years, which can...

Recent share performance context Landis+Gyr Group (SWX:LAND) has drawn attention after recent share price moves, with the stock up 3.4% on the day and 5.3% over the past week, but down over the past month. That mix of short term strength and recent weakness is prompting investors to look more closely at the company’s earnings profile, valuation signals and longer term return record before deciding how it might fit into a broader portfolio. See our latest analysis for Landis+Gyr Group. At the...

Sensirion Holding (SWX:SENS) drew attention after its stock rose about 4%, as investors reacted to 18.6% revenue growth, a small 3.4% net income decline from margin pressure, and a zero-debt, cash-generative balance sheet. See our latest analysis for Sensirion Holding. The latest 1 month share price return of 19.15% and 3 month share price return of 45.02% suggest momentum has been building, although the 3 year total shareholder return is still down 12.46%. If Sensirion’s recent move has you...

Sika (SWX:SIKA) has opened its largest US mortar production facility in Bridgeton, New Jersey, expanding automated capacity to supply key northeastern cities and infrastructure hubs, and drawing fresh attention to the stock’s recent valuation debate. See our latest analysis for Sika. The Bridgeton opening has coincided with a sharp short term rebound, with a 1 day share price return of 3.01% and a 7 day share price return of 6.14%. However, the share price remains down 10.20% year to date and...

Logitech International (SWX:LOGN) is back in focus after the board proposed lifting its Fiscal Year 2026 cash dividend to CHF 1.36 per share, alongside reporting $4.84b in revenue and diluted EPS of $4.80. See our latest analysis for Logitech International. The stock has picked up momentum recently, with a 16.6% 30 day share price return and 26.5% 90 day share price return. The 3 year total shareholder return of 53.2% contrasts with a weaker 5 year record, which suggests sentiment has...

Ypsomed Holding AG ( VTX:YPSN ) just released its yearly report and things are looking bullish. The company beat...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Helvetia...

Latest FY 2026 earnings snapshot Logitech International (SWX:LOGN) has just wrapped FY 2026 with fourth quarter revenue of US$1.1 billion and basic EPS of US$0.99, capping a year in which trailing twelve month revenue reached US$4.8 billion and EPS came in at US$4.85. Over the past two reported fourth quarters, revenue has moved from US$1,010.4 million to US$1,085.5 million while quarterly basic EPS shifted from US$0.97 to US$0.99. This gives a clearer view of how the top and bottom line are...

If you are wondering whether Sika at CHF147 is starting to look like value or still has more room to fall, the next sections will walk through what the current price actually reflects. The stock has risen 6.1% over the past week, but is still down 1.0% over the past month, 10.2% year to date and 30.7% over the past year, which may signal that investor sentiment and perceived risk have shifted several times. Recent coverage of Sika has focused on its position within the broader chemicals...

Amidst rising energy costs and inflationary pressures, European markets have faced a challenging environment, with the STOXX Europe 600 Index recently declining by 0.85%. Despite these hurdles, robust corporate earnings growth highlights opportunities for investors seeking stability through dividend stocks. In such a climate, dividend-paying stocks can offer a reliable income stream and potential resilience against market volatility.

Compagnie Financière Tradition SA ( VTX:CFT ) stock is about to trade ex-dividend in 3 days. The ex-dividend date is...

Groupe Minoteries SA ( VTX:GMI ) is about to trade ex-dividend in the next three days. The ex-dividend date is two...

Shareholders in Swiss Life Holding AG ( VTX:SLHN ) may be thrilled to learn that the analysts have just delivered a...

In May 2026, Roche Holding and its Genentech unit presented new clinical data at the ASCO Annual Meeting, showcasing nine approved and investigational oncology medicines, with a particular emphasis on giredestrant in estrogen receptor-positive breast cancer across multiple disease stages. These data, including results from large Phase III trials such as lidERA and persevERA, underline Roche’s push to expand its breast cancer portfolio with targeted therapies that could reshape treatment...

Novartis (SWX:NOVN) plans to present extensive new data on late-stage cancer and immune disease therapies, including Pluvicto, Kisqali, Scemblix and ianalumab, at the 2026 ASCO and EHA congresses. The company is progressing treatments for rare conditions such as Charcot–Marie–Tooth disease alongside its broader oncology and hematology pipeline. Novartis is also participating in a major AI industry summit, highlighting its focus on digital tools across research and development. For investors...

Ypsomed Holding (SWX:YPSN) has put up a punchy set of FY 2026 numbers, with first half revenue at CHF 362.7 million and basic EPS of CHF 10.19, alongside trailing 12 month revenue of CHF 731.0 million and EPS of CHF 16.31 after a year in which earnings grew 153.6%. Over the past reported periods, the company has seen revenue move from CHF 324.0 million in H1 FY 2025 to CHF 424.9 million in H2 FY 2025 and then to CHF 362.7 million in H1 FY 2026, while EPS shifted from CHF 2.39 to CHF 4.02 and...

Recent share performance and business scale Nestlé (SWX:NESN) has drawn fresh investor attention after a recent stretch of mixed returns, with the stock up over the past month but down over the past 3 years and past 5 years. The company closed at CHF 78.80, with a return of about 0.2% over the past day, 2.5% over the past week and 4.6% over the past month, while the share price declined about 2.6% over the past 3 months. Over longer periods, Nestlé’s total return is up about 3.1% year to date...